Could a tiny neck implant calm rheumatoid arthritis without pills?
NCT ID NCT04539964
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a small device implanted on the vagus nerve in the neck to treat moderate to severe rheumatoid arthritis. About 243 adults who did not get enough relief from standard drugs will receive either active or inactive stimulation for 12 weeks, then all will receive active stimulation for long-term follow-up. The goal is to see if the device safely reduces joint swelling and pain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
243 people
The number who actually took part.
- Started
-
Jan 2021
- Expected to finish
-
Oct 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
22 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 22-75 years of age at screening * Active moderate or severe RA, defined as at least 4/28 tender and 4/28 swollen joints * Demonstrated an inadequate response, loss of response, or intolerance to 1 or more approved for rheumatoid arthritis biologic or targeted synthetic Disease-Modifying Anti-Rheumatic Drugs (DMARDs), including Janus kinase inhibitors (JAKi) * Receiving treatment with at least 1 conventional synthetic DMARD for at least 12 weeks and on a continuous non-changing dose and route of administration for at least 4 weeks prior to Screening and able to continue the same stable dose through Week 12 Exclusion Criteria: * Untreated or poorly controlled psychiatric illness or history of substance abuse * Significant immunodeficiency due to underlying illness * History of stroke or transient ischemic attack, or diagnosis of cerebrovascular fibromuscular dysplasia * Clinically significant cardiovascular disease * Neurological syndromes, including multiple sclerosis, Alzheimer's disease, or Parkinson's disease * Uncontrolled fibromyalgia * History of left or right carotid surgery * History of unilateral or bilateral vagotomy, partial or complete splenectomy * Recurrent vasovagal syncope episodes * Current, regular use of tobacco products * Hypersensitivity/allergy to MRI contrast agents and/or unable to perform MRI
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Rheumatoid arthritis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Albuquerque Center for Rheumatology
Albuquerque, New Mexico, 87102, United States
-
Annapolis Rheumatology
Fairfax, Virginia, 22033, United States
-
Arizona Arthritis & Rheumatology Research, PLLC
Tucson, Arizona, 85704, United States
-
Arizona Arthritis Rheumatology & Research, PLLC
Phoenix, Arizona, 85037, United States
-
Arizona Arthritis ans Rheumatology Research, PPLC
Mesa, Arizona, 85210, United States
-
Arthritis & Osteoporosis Consultants Of The Carolinas
Charleston, North Carolina, 28202, United States
-
Arthritis & Rheumatic Disease Specialties
Aventura, Florida, 33180, United States
-
Arthritis & Rheumatology Research Institute, PLLC
Allen, Texas, 75013, United States
-
Augusta University
Augusta, Georgia, 30912, United States
-
Austin Regional Clinic
Austin, Texas, 78717, United States
-
Bay Area Rheumatology
Clearwater, Florida, 33765, United States
-
Biopharma Informatic
Houston, Texas, 77043, United States
-
Central Texas Rheumatology Associates
Austin, Texas, 78746, United States
-
Clinical Trials of Texas, Inc
San Antonio, Texas, 78229, United States
-
DJL Clinical Research
Charlotte, North Carolina, 28210, United States
-
Delaware Arthritis
Lewes, Delaware, 19958, United States
-
HARAC Research Corporation
Avon Park, Florida, 33825, United States
-
Health Research of Oklahoma, PLLC
Oklahoma City, Oklahoma, 73103, United States
-
IRIS Research and Development
Plantation, Florida, 33324, United States
-
Inland Rheumatology Clinical Trials
Upland, California, 91786, United States
-
June DO, PC
Lansing, Michigan, 48910, United States
-
Kansas City Physician Partners
Kansas City, Missouri, 64151, United States
-
Lehigh Valley Health Network
Allentown, Pennsylvania, 18103, United States
-
Long Island Regional Arthritis & Osteoporosis Care
Babylon, New York, 11702, United States
-
Massachusetts General Hospital Division of Rheumatology, Allergy, and Immunology
Boston, Massachusetts, 02114, United States
-
Medvin Clinical Research
Covina, California, 91722, United States
-
Medvin Clinical Research
Whittier, California, 90602, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
Parris and Associates Rheumatology
Lawrenceville, Georgia, 30044, United States
-
Physician Research Collaboration, LLC
Lincoln, Nebraska, 68516, United States
-
Precision Comprehensive Clinical Research Solutions
Colleyville, Texas, 76034, United States
-
RecioMed Clinical Research Network, Inc.
Boynton Beach, Florida, 33472, United States
-
Saint Paul Rheumatology, P.A.
Eagan, Minnesota, 55121, United States
-
Sound Clinical Research, LLC
Bothell, Washington, 98021, United States
-
Southwest Rheumatology Research LLC
Mesquite, Texas, 75150, United States
-
Stamford Therapeutics Consortium
Stamford, Connecticut, 06905, United States
-
Tekton Research
Austin, Texas, 78745, United States
-
The Arthritis & Rheumatology Clinic of Northern Colorado
Fort Collins, Colorado, 80528, United States
-
University of Pennsylvania Medical Center
Philadelphia, Pennsylvania, 19104, United States
-
West County Rheumatology
St Louis, Missouri, 63122, United States
-
West Virginia University
Morgantown, West Virginia, 26506, United States
-
Willow Rheumatology and Wellness PLLC
Willowbrook, Illinois, 60527, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new ankle? researchers track 400 people with an implant meant to restore movement
- Can a Job-Focused rehab program keep arthritis patients employed?
- Do rheumatic diseases quietly damage the Eye's oil glands?
- Hidden kidney damage may lurk in rheumatoid arthritis patients
- Can a new injection calm rheumatoid arthritis? an early trial puts ZB002 to the test
- Can a new knee implant design offer better Long-Term relief?